Mirae Asset Global Investments Co., Ltd. Harmony Biosciences Holdings, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,900 shares of HRMY stock, worth $67,032. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,900
Previous 2,056
7.59%
Holding current value
$67,032
Previous $82,000
20.73%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding HRMY
# of Institutions
255Shares Held
46.7MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$233 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$206 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$167 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$80.4 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$55.8 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.09B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...